City University of Hong Kong
ðŸ‡ðŸ‡°Hong Kong, China
- Country
- ðŸ‡ðŸ‡°Hong Kong, China
- Ownership
- Private
- Established
- 1984-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.cityu.edu.hk
GenEditBio Secures Investment to Advance Genome Editing Technologies
• GenEditBio has received strategic investment from Gobi Partners GBA to accelerate the development of its genome editing technologies.
• The funding will support the advancement of GenEditBio's _in vivo_ programs and the initiation of clinical studies for safety and efficacy.
• GenEditBio's GEB-400 program, targeting an inherited retinal disease, is expected to enter the clinical stage in 2025.
• The company focuses on providing affordable "precision DNA surgery" for genetic diseases with unmet needs.
© Copyright 2025. All Rights Reserved by MedPath